Pages that link to "Q85010396"
Jump to navigation
Jump to search
The following pages link to CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model (Q85010396):
Displaying 49 items.
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents (Q26747054) (← links)
- CXCR4 in breast cancer: oncogenic role and therapeutic targeting (Q26781915) (← links)
- Use of rodents as models of human diseases (Q26822856) (← links)
- CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain (Q27009526) (← links)
- CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment (Q33677057) (← links)
- Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma (Q33775283) (← links)
- CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells (Q34476278) (← links)
- Small molecule inhibitors of CXCR4. (Q34574987) (← links)
- Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway (Q34694101) (← links)
- Breast cancer at bone metastatic sites: recent discoveries and treatment targets. (Q34939979) (← links)
- Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists (Q35036663) (← links)
- Targeting tumor cell motility to prevent metastasis. (Q35095152) (← links)
- The prognostic value of CXCR4 in ovarian cancer: a meta-analysis (Q35127922) (← links)
- Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy (Q35666361) (← links)
- Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection (Q35713406) (← links)
- SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction. (Q35732102) (← links)
- Process of hepatic metastasis from pancreatic cancer: biology with clinical significance (Q35739397) (← links)
- Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Q35836868) (← links)
- The mesenchymal tumor microenvironment: a drug-resistant niche (Q36187755) (← links)
- Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling (Q36413560) (← links)
- The Role of chemokine receptor CXCR4 in breast cancer metastasis (Q36562896) (← links)
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases (Q36747524) (← links)
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy (Q37079141) (← links)
- Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma (Q37231081) (← links)
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients (Q37685449) (← links)
- Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? (Q37883011) (← links)
- Emerging targeted agents in metastatic breast cancer (Q38086421) (← links)
- Specific protein markers for stem cell cross-talk with neighboring cells in the environment (Q38175402) (← links)
- Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. (Q38650120) (← links)
- Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells (Q38814109) (← links)
- Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC. (Q38840383) (← links)
- CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy (Q39284720) (← links)
- Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. (Q39442795) (← links)
- CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. (Q40724369) (← links)
- Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis (Q41143566) (← links)
- Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis. (Q41438471) (← links)
- CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells (Q42033255) (← links)
- Discovery of novel N-aryl piperazine CXCR4 antagonists (Q42144564) (← links)
- Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. (Q42845461) (← links)
- Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy (Q47850217) (← links)
- High expression of SDF-1 and VEGF is associated with poor prognosis in patients with synovial sarcomas (Q49875919) (← links)
- Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis (Q50100841) (← links)
- Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer. (Q52559698) (← links)
- CXCR4 antagonists for treatment of breast cancer (Q57493691) (← links)
- GPCR Modulation in Breast Cancer (Q60921607) (← links)
- CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model (Q87652766) (← links)
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial (Q88506076) (← links)
- Recruitment of Intratumoral CD103+ Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity (Q92436840) (← links)
- Bone Metastasis of Breast Cancer (Q92917018) (← links)